ScholarIQanswers from OpenAlex & ORCID
David W. Larson
ResearcherPublications, citations & collaboration network
David W. Larson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David W. Larson have?
ScholarIQindexed works
David W. Larson has 459 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David W. Larson have?
ScholarIQcitation count
David W. Larson has 13,799 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David W. Larson?
ScholarIQh-index
David W. Larson has an h-index of 55 in OpenAlex.
What is the i10-index of David W. Larson?
ScholarIQi10-index
David W. Larson has an i10-index of 213 in OpenAlex.
What is the ORCID of David W. Larson?
ScholarIQorcid
The ORCID for David W. Larson is on the source record.
What is the OpenAlex record for David W. Larson?
ScholarIQopenalex
The OpenAlex for David W. Larson is on the source record.
What are the most-cited papers on David W. Larson?
ScholarIQmost cited works
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz, George J. Chang, Michael J. Overman, Cathy Eng, Daniel J. Sargent, David W. Larson, Axel Grothey, Jean‐Nicolas Vauthey, David M. Nagorney, Robert R. McWilliams
Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes
James W. Fleshman, Megan E. Branda, Daniel J. Sargent, Anne Marie Boller, Virgilio George, Maher A. Abbas, Walter R. Peters, Dipen Maun, George J. Chang, Alan J. Herline, Alessandro Fichera, Matthew G. Mutch, Steven D. Wexner, Mark H. Whiteford, John H. Marks, Elisa H. Birnbaum, David A. Margolin, David W. Larson, Peter W. Marcello, Mitchell C. Posner, Thomas E. Read, John R.T. Monson, Sherry M. Wren, Peter W. T. Pisters, Heidi Nelson
Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer
James W. Fleshman, Megan E. Branda, Daniel J. Sargent, Anne Marie Boller, Virgilio George, Maher A. Abbas, Walter R. Peters, Dipen Maun, George J. Chang, Alan J. Herline, Alessandro Fichera, Matthew G. Mutch, Steven D. Wexner, Mark H. Whiteford, John H. Marks, Elisa H. Birnbaum, David A. Margolin, David W. Larson, Peter W. Marcello, Mitchell C. Posner, Thomas E. Read, John R.T. Monson, Sherry M. Wren, Peter W. T. Pisters, Heidi Nelson
Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract
Pedro J. Gomez‐Pinilla, Simon J. Gibbons, Michael R. Bardsley, Andrea Lörincz, Marı́a J. Pozo, Pankaj J. Pasricha, Matt van de Rijn, Robert B. West, Michael G. Sarr, Michael L. Kendrick, Robert R. Cima, Eric J. Dozois, David W. Larson, Tamás Ördög, Gianrico Farrugia
Effect of Infliximab on Short-Term Complications in Patients Undergoing Operation for Chronic Ulcerative Colitis
Chelliah Selvasekar, Robert R. Cima, David W. Larson, Eric J. Dozois, Jeffrey R. Harrington, William S. Harmsen, Edward V. Loftus, William J. Sandborn, Bruce G. Wolff, John H. Pembérton